Strategy Asset Managers’s Boston Scientific BSX Stock Holding History

Strategy Asset Managers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,876	Closed	-$682K	–	268
2026 Q1	$682K	Sell	10,876 -9,134	-46%	-$731K	0.11%	132
2025 Q4	$1.91M	Buy	20,010 +527	+3%	+$51.7K	0.31%	66
2025 Q3	$1.9M	Sell	19,483 -233	-1%	-$24.1K	0.34%	61
2025 Q2	$2.12M	Sell	19,716 -109	-0.5%	-$11K	0.4%	58
2025 Q1	$2M	Buy	19,825 +399	+2%	+$40.2K	0.41%	59
2024 Q4	$1.74M	Sell	19,426 -814	-4%	-$71.7K	0.34%	62
2024 Q3	$1.7M	Buy	20,240 +12,265	+154%	+$967K	0.33%	62
2024 Q2	$431K	Sell	7,975 -2,464	-24%	-$180K	0.1%	147
2024 Q1	$715K	Buy	10,439 +1,605	+18%	+$103K	0.15%	109
2023 Q4	$511K	Buy	8,834 +153	+2%	+$8.17K	0.12%	126
2023 Q3	$458K	Buy	8,681 +706	+9%	+$37K	0.12%	132
2023 Q2	$431K	Sell	7,975 -187	-2%	-$9.77K	0.1%	147
2023 Q1	$408K	Buy	8,162 +331	+4%	+$15.6K	0.1%	143
2022 Q4	$362K	Sell	7,831 -54	-0.7%	-$2.34K	0.09%	162
2022 Q3	$305K	Buy	+7,885	New	+$316K	0.08%	172
2022 Q1	–	Sell	-8,108	Closed	-$344K	–	255
2021 Q4	$344K	Buy	+8,108	New	+$341K	0.09%	143
2019 Q2	–	Sell	-480	Closed	-$18K	–	132
2019 Q1	$18K	Sell	480 -48,383	-99%	-$1.85M	﹤0.01%	178
2018 Q4	$1.73M	Sell	48,863 -43,191	-47%	-$1.57M	0.42%	60
2018 Q3	$3.54M	Buy	+92,054	New	+$3.22M	0.72%	34
2016 Q4	–	Sell	-104,095	Closed	-$2.48M	–	129
2016 Q3	$2.48M	Buy	+104,095	New	+$2.48M	0.56%	64
2016 Q1	–	Sell	-131,461	Closed	-$2.42M	–	143
2015 Q4	$2.42M	Buy	131,461 +281	+0.2%	+$5.04K	0.55%	61
2015 Q3	$2.15M	Buy	+131,180	New	+$2.24M	0.52%	64

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strategy Asset Managers's BSX Position: Q2 2026 in Review

Strategy Asset Managers sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,876 shares — an estimated $682K sold.

Strategy Asset Managers first reported a position in BSX in Q3 2015 and held it in 22 quarters. The position peaked at $3.54M in Q3 2018. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Strategy Asset Managers reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Strategy Asset Managers sold 10,876 Boston Scientific shares in Q2 2026, an estimated $682K.
Strategy Asset Managers first reported a position in Boston Scientific in Q3 2015 and held it in 22 quarters.
Strategy Asset Managers's Boston Scientific position peaked at $3.54M in Q3 2018.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Strategy Asset Managers's 13F filing for Q2 2026, filed 14 Aug 2026.